Naples, Florida Sep 21, 2022 (Issuewire.com) - Today is another good day to let you know that stem cell therapies are slowly gaining consideration worldwide. Seeing the rapid pace in stem cell research and practical solutions presented in the medical field, it's not wrong to say,
"Sooner or later comes a time when patients have options other than Surgery."
Realizing the importance and value of stem cells, many professionals in this field are trying hard to make non-invasive treatment a reality. One such professional is Dr. David Greene, an orthopedic surgeon and founder of R3 Stem Cell.
He and his team of experts help their patients improve their lives with effective stem cell therapies. For his work, Dr. Greene has recently been featured in the Cover story of "10 Best Healthcare Companies to Watch in 2022" by Silicon Review Magazine.
Dr. Greene's words:
I appreciate the honor, and my goal is to continue growing so we can help more patients to improve their quality lives. — David Greene, MD, Ph.D., MBA
R3 has become the global leader by providing effective and safe regenerative therapies for more than 50 conditions for over a decade. However, they believe that regenerative therapies are relatively new medical treatments. So it is important that patients must have accurate knowledge to know what the procedure can and cannot do.
R3 provides regenerative treatments in six countries, with biologics that are not only the finest but safe and also come with high stem cell counts. It doesn't stop here; their treatments are cost-effective worldwide so that more patients get a chance to live a normal and healthy life.
Their 45 centers have performed 20,000 regenerative therapies for various medical conditions. The combination of quality, safety, and cost-effectiveness has pushed R3 Stem Cell as the worldwide leader for patients who desire the best and most effective treatment.
According to Dr. David Greene R3 Stem Cell, "we made patients understand that regenerative therapies are not a one-time cure." They are extremely beneficial, but the treatment needs to be repeated.
So, "to make the repeat procedure within reach of patients and their families. We lean towards volume buying to reduce the cost of procedures." Besides regenerative therapies treatment, Dr. David Greene R3 Stem Cell is also working towards increasing awareness about Stem Cell Therapy.
As per the R3 CEO Dr. Greene, "Education is the cornerstone of our approach to involving the public."
We have published hundreds of consumer guides, videos, and educational articles to make this possible and started our Stem Cell Master Class. In fact, R3 Medical Training was created to provide knowledge to interested people in regenerative therapy with the CME-accredited training course for continuing medical education.
The course offers medical professionals valuable training over two days, allowing providers to be well-trained in regenerative medicine and their techniques in practice. Furthermore, they also provide aesthetic medicine training with PRP, exosomes, fillers, and neurotoxins. R3 Medical Research is leading the way in regenerative medicine as a Healthcare Company to Watch. In addition, R3 will be opening in several new countries over the next year.
In the end, Stem Cell Research deserves support, support to make breakthroughs in the medical field.
Media Contact
Harry R. Goddard *****@jourrapide.com
